April 17, 2019: The global enteral feeding formulas market size is expected to reach USD 8.71 billion by 2025, at a CAGR 7.2% over a forecast period, according to a new report by Radiant , Inc. It is majorly driven by growing prevalence of chronic diseases including cancer, diabetes, inflammatory bowel disease, liver disease, and neurological conditions. Manufacturers are increasingly focusing on developing formulas that cater to specific therapeutic needs of these patients. Rise in number of preterm births is also one of the significant factors that propel the product demand to meet nutritional requirements of the newborns.
Increasing number of home care and nursing care centers also indicates the surge in demand for these formulas, as a large number of chronically ill as well as geriatric patients are the key consumers for these products. Growing demand for these products for treating conditions associated with pregnancy also contributes to market growth. In addition, recent product developments and rise in number of new product launches may positively impact the growth.
Request a Free Sample Copy of Enteral Feeding Formulas Market Report @ https://www.radiantinsights.com/research/enteral-feeding-formulas-market/request-sample
Rise in prevalence of hospital associated malnutrition among both adults and children drives the demand for enteral feeding formulas. Increasing implementation of the number of government programs for creating awareness regarding enteral tube feeding may also support increasing adoption. Moreover, favorable reimbursement policies in developed countries cover tube feeding procedures that may impel the enteral feeding formulas market over the forecast period.
Further key findings from the report suggest:
• Disease-specific formula segment is expected to emerge at the fastest CAGR of 8.6% over the forecast period owing to high prevalence of chronic diseases coupled with recent product developments
• Adults segment held the largest market share in terms of revenue in 2018 due to high availability and increased adoption of tube feeding formulas among adults
• In 2018, oncology led the application segment with the largest revenue share owing high prevalence of cancer induced malnutrition
• Home care end use segment is expected to grow lucratively over the forecast period
• North America held the largest revenue share in 2018 owing to favorable reimbursement policies and rising burden of cardiovascular diseases
• Asia Pacific is expected to witness the fastest CAGR 8.7% over the forecast period
• The enteral feeding formulas market is fairly competitive with the presence of companies such as Abbott; Nestle Health Science, Danone Nutricia; Fresenius Kabi AG; and MEIJI HOLDING AND CO.
Download Full Research Report on “Enteral Feeding Formulas Market” @ https://www.radiantinsights.com/research/enteral-feeding-formulas-market
Table of Contents
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources & third-party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Enteral Feeding Formulas Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospects Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.4 List of Key End-users
No comments:
Post a Comment